Hide Board Information

Show Board Information

Biora Therapeutics, Inc. BIORQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 05/22/2023 6:06:38 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Biora Therapeutics, Inc. (OTCMRKTS: BIORQ) Stock Message Board

1. BIORQ Company Profile

    

2. BIORQ Time & Sales

    

3. BIORQ Recent News

    

4. BIORQ Filings

    

5. BIORQ Financials

    

6. BIORQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	$BIOR 31% v1,5M c4.85 f11,859M H5.10 ML2.26	znewcar1	05/22/2023 6:06:38 PM
5	$BIOR 155% v50,1M c5.40 f8,926M H5.63 ML1.95 off	znewcar1	01/10/2023 4:43:02 PM
4	BIOR 31% v30,9M c1.01 f184,2M H1.15 ML.6211	znewcar1	08/10/2022 5:36:14 PM
3	@1.28 still a bear	znewcar1	02/23/2022 1:30:51 PM
2	H2.11 @ 1.5 ML@1.11 downward slide (1)	znewcar1	02/18/2022 1:19:36 PM
1	PROG Stock Chart Video Analysis 02-08-2022	Chasing Stars	02/08/2022 8:14:59 PM

Recent Articles

• Trump's Tariffs Projected To Reduce Federal Deficit Significantly
• Kimbal Musk Advocates for Elon's Pay Package Amid Controversy
• Ethereum's Soaring Success: A Historic Shift in Crypto Market
• Apple's Strategic Move to Revitalize Siri with Google AI
• Graphite One Secures Incentive Awards for Growth Initiatives
• Strengthening Cooperation: China’s Vision for the SCO Community
• Graphite One Implements Long-Term Incentive Awards for Growth
• Debate Ignites Over Trump's Intel Stake and Semiconductor Future
• Palantir Technologies Faces Challenges Amid Stock Activity
• Investors Notified of Class Action Lawsuit Against KinderCare
• Neogen Corporation Faces Legal Challenges Amid Revenue Decline
• Important Update for Sable Offshore Investors and Class Action Lawsuits
• Understanding Your Rights in the SelectQuote Class Action
• Understanding the Flywire Corporation Class Action Lawsuit Update
• Navigating Interest Rate Changes: Impact on Tech and Growth Stocks
• Travelers Seek Authentic Connections Over Digital Distractions
• Investors Eye Luminar Technologies: Join the Class Action Now
• LifeMD, Inc. Investors Encouraged to Join Class Action Inquiry
• Explore the New North River Farms Community by Lennar
• Lennar Unveils North River Farms Master-Planned Homes
• Investors Gear Up for KinderCare Learning Class Action Lawsuit
• Investors Can Take Action in Lineage, Inc. Legal Matters
• Investors Consider Class Action Against Lockheed Martin Corporation
• Record Viewership and Exciting Growth for the Premier Lacrosse League
• Palma School Celebrates the Renewal of Edward M. Dowd Gym
• Faircourt Asset Management Announces Exciting Fund Distribution
• Novo Nordisk A/S Investors Urged to Take Timely Action Now
• Investors in Replimune Can Secure Their Rights Now
• SelectQuote Inc Faces Class Action Amid Serious Allegations
• Investment Growth: What $100 in S&P Global Would Be Today
• Heatherwood Senior Living Welcomes New Culinary Director
• A Deep Dive into Mr. Cooper Group's Impressive 5-Year Growth
• Investors Urged to Take Action in Snap Inc. Class Action
• Class Action Suit Against PubMatic: Investors Take Notice
• Transformative Growth of Encompass Health: A 15-Year Journey
• Discover the Compact 1MORE Pixie Mini Microphone for Creators
• Novo Nordisk Investors: Join the Class Action Today for Justice
• Investors in Replimune Group, Inc. Should Act Now for Legal Claims
• Mustang Energy's Progress on Surprise Creek and Ford Lake Projects
• Five-Year Performance Analysis of Vertiv Holdings Stock
• Transform Your $100 Investment into Over $500 with TPL
• Tigé Boats Unveils the All-New RZX Class for a Luxurious Ride
• Metalsource Mining Secures Significant Loan for Development
• Protecting Your Investment: Navigating Class Actions for RXST
• SaferWatch Enhances Public Safety Accessibility with New Contract
• Investors Alert: Join Luminar Technologies' Class Action Now
• Investors of Lockheed Martin Corporation Should Act Now!
• Elite Express Holding Inc. Successfully Completes IPO of $15.2M
• Levi & Korsinsky Engages in Class Action for C3.ai Investors
• Discover the Returns of Gilead Sciences Stock Over Two Decades